These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26722056)

  • 1. METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.
    Launay S; Sabatier R; Brunelle S; Esterni B; Tarpin C; Viret F; Gravis G; Cappiello M; Provansal M; Extra JM; Bertucci F; Viens P; Goncalves A
    Anticancer Res; 2016 Jan; 36(1):293-9. PubMed ID: 26722056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.
    Wong NS; Buckman RA; Clemons M; Verma S; Dent S; Trudeau ME; Roche K; Ebos J; Kerbel R; Deboer GE; Sutherland DJ; Emmenegger U; Slingerland J; Gardner S; Pritchard KI
    J Clin Oncol; 2010 Feb; 28(5):723-30. PubMed ID: 20026801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.
    Pramanik R; Agarwala S; Gupta YK; Thulkar S; Vishnubhatla S; Batra A; Dhawan D; Bakhshi S
    JAMA Oncol; 2017 Sep; 3(9):1222-1227. PubMed ID: 28384657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer.
    Yoshimoto M; Takao S; Hirata M; Okamoto Y; Yamashita S; Kawaguchi Y; Takami M; Furusawa H; Morita S; Abe C; Sakamoto J
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):331-8. PubMed ID: 22526409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer.
    Tan EH; Tan DS; Li WY; Haaland B; Ang MK; Chau NM; Toh CK; Tan IB; Koh TS; Thng CH; Chowbay B; Hui KM; Lim WT; Ng QS
    Lung Cancer; 2015 Jun; 88(3):289-96. PubMed ID: 25896396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
    Katsaounis P; Kotsakis A; Agelaki S; Kontopodis E; Agelidou A; Kentepozidis N; Vamvakas L; Christopoulou A; Karachaliou N; Hatzidaki D; Georgoulias V
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):821-7. PubMed ID: 25702051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma.
    Rueda A; García-Sanz R; Pastor M; Salar A; Labrador J; Quero-Blanco C; Casanova M; Provencio M;
    Acta Oncol; 2015 Jun; 54(6):933-8. PubMed ID: 25734915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic chemotherapy in advanced oral cancers.
    Patil V; Noronha V; D'cruz AK; Banavali SD; Prabhash K
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S106-10. PubMed ID: 22322727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.
    Montagna E; Cancello G; Bagnardi V; Pastrello D; Dellapasqua S; Perri G; Viale G; Veronesi P; Luini A; Intra M; Calleri A; Rampinelli C; Goldhirsch A; Bertolini F; Colleoni M
    Clin Breast Cancer; 2012 Jun; 12(3):207-14. PubMed ID: 22520733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort.
    Chi KH; Ko HL; Yang KL; Lee CY; Chi MS; Kao SJ
    Oncotarget; 2015 Jun; 6(18):16735-45. PubMed ID: 25944689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.
    Raimondi A; Corallo S; Niger M; Antista M; Randon G; Morano F; Milione M; Kusamura S; Baratti D; Guaglio M; Cremolini C; Marmorino F; Di Bartolomeo M; Deraco M; De Braud F; Pietrantonio F
    Clin Colorectal Cancer; 2019 Jun; 18(2):e179-e190. PubMed ID: 31023524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience.
    Zapletalova D; André N; Deak L; Kyr M; Bajciova V; Mudry P; Dubska L; Demlova R; Pavelka Z; Zitterbart K; Skotakova J; Husek K; Martincekova A; Mazanek P; Kepak T; Doubek M; Kutnikova L; Valik D; Sterba J
    Oncology; 2012; 82(5):249-60. PubMed ID: 22538363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma.
    Shao YY; Lin ZZ; Hsu C; Lee KD; Hsiao CH; Lu YS; Huang CC; Shen YC; Hsu CH; Cheng AL
    Oncology; 2012; 82(1):59-66. PubMed ID: 22310088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer.
    Alagizy HA; Shehata MA; Hashem TA; Abdelaziz KK; Swiha MM
    Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):22-7. PubMed ID: 25528114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients.
    Derosa L; Galli L; Orlandi P; Fioravanti A; Di Desidero T; Fontana A; Antonuzzo A; Biasco E; Farnesi A; Marconcini R; Francia G; Danesi R; Falcone A; Bocci G
    Cancer; 2014 Dec; 120(24):3923-31. PubMed ID: 25111199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
    Orlando L; Cardillo A; Ghisini R; Rocca A; Balduzzi A; Torrisi R; Peruzzotti G; Goldhirsch A; Pietri E; Colleoni M
    BMC Cancer; 2006 Sep; 6():225. PubMed ID: 16978400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.
    Ekinci D; Kargi A; Yalcin AD; Savas B
    J BUON; 2013; 18(1):245-52. PubMed ID: 23613412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study.
    Morganti AG; Massaccesi M; Caravatta L; Macchia G; Picardi V; Deodato F; Ippolito E; Mignogna S; Ferro M; Cilla S; Mattiucci GC; Valentini V
    Anticancer Res; 2013 Oct; 33(10):4585-9. PubMed ID: 24123034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of metronomic administration of paclitaxel for advanced recurrent non-small-cell lung cancer.
    Noronha V; Patil VM; Joshi A; Prabhash K
    Indian J Cancer; 2013; 50(2):122-7. PubMed ID: 23979203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.